HIV treatment as prevention: In the real world the details matter

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 3, 2011, Pages

  Cohen, Myron S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE TRANSMISSION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION PREVENTION; INFECTION RISK; LETTER; NONHUMAN; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 79951806202     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182041968     Document Type: Letter

References (7)

1. Cohen MS, Gay C. Treatment to prevent HIV transmission. Clin Infect Dis. 2010;50:(Suppl 3): S85-S95.
2. Donnell D, Baeten JM, Kiarie J, et al. Heterosexual HIV-1 transmission antiretroviral therapy: a prospective cohort analysis. Lancet. 2010;375: 2092-2098.
3. Wood E, Kerr T, Marshall B, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338: b1649.
4. Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376:532-539.
5. Das, M, Cu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5:e11068.
6. Powers, KA, Poole, C, Pettifore AE, et al. Rethinking the heresosexual tramsission of HIV-1: A systematic review and meta-analysis. Lancet Infect Dis. 2010;8:553-563.
7. Cu-Uvin S, Delong AK, Ventakesh KK, et al. Genital tract HIV-1 RNA shedding in women with below detectable plasma viral load. AIDS. 2010;24:2489-2497.